Cargando…

HCC: RNA-Sequencing in Cirrhosis

Hepatocellular carcinoma (HCC) ranks the most common types of cancer worldwide. As the fourth leading cause of cancer-related deaths, its prognosis remains poor. Most patients developed HCC on the basis of chronic liver disease. Cirrhosis is an important precancerous lesion for HCC. However, the mol...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Haoyu, Shi, Wenjie, Lu, Jing, Liu, Yuan, Zhou, Wei, Yu, Zekun, Qin, Shengying, Fan, Junwei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9855755/ https://www.ncbi.nlm.nih.gov/pubmed/36671526 http://dx.doi.org/10.3390/biom13010141

Ejemplares similares

Evaluating Distribution and Prognostic Value of New Tumor-Infiltrating Lymphocytes in HCC Based on a scRNA-Seq Study With CIBERSORTx
por: Li, Lixing, et al.
Publicado: (2020)

Diabetes and the risk of cirrhosis and HCC: An analysis of the UK Biobank
por: Ye, Fangzhou, et al.
Publicado: (2023)

Cytokeratin-18 in Diagnosis of HCC in Patients with Liver Cirrhosis
por: Ismail, Saber A, et al.
Publicado: (2017)

Tenofovir disoproxil fumarate reduce incidence of HCC development in CHB-patients with compensated cirrhosis
por: Zhang, Ping, et al.
Publicado: (2018)

Single-cell RNA sequencing reveals the mediatory role of cancer-associated fibroblast PTN in hepatitis B virus cirrhosis-HCC progression
por: Lin, Chenhong, et al.
Publicado: (2023)

Tenofovir is superior to entecavir in reducing HCC for patients with HBV-related compensated cirrhosis at high HCC risk scores
por: Huang, Yan, et al.
Publicado: (2022)

Single-Cell RNA-Seq Analysis Reveals Microenvironmental Infiltration of Plasma Cells and Hepatocytic Prognostic Markers in HCC With Cirrhosis
por: Zhang, Siwen, et al.
Publicado: (2020)

Progression of liver cirrhosis to HCC: an application of hidden Markov model
por: Bartolomeo, Nicola, et al.
Publicado: (2011)

Upregulation of Serum Sphingosine (d18:1)-1-P Potentially Contributes to Distinguish HCC Including AFP-Negative HCC From Cirrhosis
por: Jiang, Yingying, et al.
Publicado: (2020)

Evaluation of D-TACE combined with endovascular brachytherapy for HCC with MPVTT
por: Huang, Wei, et al.
Publicado: (2022)

In silico analysis excavates potential biomarkers by constructing miRNA-mRNA networks between non-cirrhotic HCC and cirrhotic HCC
por: Ding, Bisha, et al.
Publicado: (2019)

Circulating Cytokines Reflect the Etiology-Specific Immune Environment in Cirrhosis and HCC
por: Beudeker, Boris J. B., et al.
Publicado: (2022)

Accurate prediction of HCC risk after SVR in patients with hepatitis C cirrhosis based on longitudinal data
por: Zou, Yanzheng, et al.
Publicado: (2023)

Advances in the Study of Bioactive Nanoparticles for the Treatment of HCC and Its Postoperative Residual Cancer
por: Li, Yanxu, et al.
Publicado: (2023)

A synthetic dsRNA, as a TLR3 pathwaysynergist, combined with sorafenib suppresses HCC in vitro and in vivo
por: Xu, Yu-Yin, et al.
Publicado: (2013)

Surveillance Program for Diagnosis of HCC in Liver Cirrhosis: Role of Ultrasound Echo Patterns
por: Soresi, Maurizio, et al.
Publicado: (2017)

More Pronounced Hypercoagulable State and Hypofibrinolysis in Patients With Cirrhosis With Versus Without HCC
por: Zanetto, Alberto, et al.
Publicado: (2021)

Global epidemiology of alcohol-associated cirrhosis and HCC: trends, projections and risk factors
por: Huang, Daniel Q., et al.
Publicado: (2022)

Retraction Note: A synthetic dsRNA, as a TLR3 pathwaysynergist, combined with sorafenib suppresses HCC in vitro and in vivo
por: Xu, Yu-Yin, et al.
Publicado: (2023)

Effects of statins and aspirin on HCC risk in alcohol-related cirrhosis: nationwide emulated trials
por: Kraglund, Frederik, et al.
Publicado: (2023)

Genetic Polymorphisms of Fas/FasL Promoter Associated with Hepatitis C cirrhosis and HCC
por: Abed, Sally, et al.
Publicado: (2017)

Aggressive primary gastric lymphoma (PGL) masquerading as hepatocellular cancer (HCC) in alcoholic cirrhosis
por: Ahmed, Moiz, et al.
Publicado: (2021)

SNORA23 inhibits HCC tumorigenesis by impairing the 2′-O-ribose methylation level of 28S rRNA
por: Liu, Zhiyong, et al.
Publicado: (2022)

Comparing MicroRNA Profilings of Purified HER-2-Negative and HER-2-Positive Cells Validates miR-362-5p/Sema3A as Characteristic Molecular Change in Triple-Negative Breast Cancers
por: Zhang, Xiaoqing, et al.
Publicado: (2019)

The role of lamivudine versus entecavir in prevention of HCC in patients with hepatitis B virus-related cirrhosis
por: Olariu, Cristina, et al.
Publicado: (2013)

Influence of surgical approach and quality of resection on the probability of cure for early-stage HCC occurring in cirrhosis
por: Hobeika, Christian, et al.
Publicado: (2020)

Genetic polymorphisms related to the vitamin D pathway in patients with cirrhosis with or without hepatocellular carcinoma (HCC)
por: de Jesus Brait, Beatriz, et al.
Publicado: (2022)

RYBP expression is associated with better survival of patients with hepatocellular carcinoma (HCC) and responsiveness to chemotherapy of HCC cells in vitro and in vivo
por: Wang, Wei, et al.
Publicado: (2014)

HCC incidence after hepatitis C cure among patients with advanced fibrosis or cirrhosis: A meta‐analysis
por: Lockart, Ian, et al.
Publicado: (2022)

Assessment of prognostic role of a novel 7-lncRNA signature in HCC patients
por: Qu, Junchi, et al.
Publicado: (2023)

Olfm4 Is Highly Expressed in HCC Patients and as a Biomarker and Therapeutic Target for HCC
por: Wei, Yulong, et al.
Publicado: (2021)

Single-cell immune signature for detecting early-stage HCC and early assessing anti-PD-1 immunotherapy efficacy
por: Shi, Jiawei, et al.
Publicado: (2022)

Novel Single Nucleotide Polymorphisms in Interleukin 6 Affect Tacrolimus Metabolism in Liver Transplant Patients
por: Chen, Dawei, et al.
Publicado: (2013)

Promoting Colonization in Metastatic HCC Cells by Modulation of Autophagy
por: Peng, Yuan-Fei, et al.
Publicado: (2013)

Development of a Non‐Coding‐RNA‐based EMT/CSC Inhibitory Nanomedicine for In Vivo Treatment and Monitoring of HCC
por: Guo, Ruomi, et al.
Publicado: (2019)

PGAM1 Inhibition Promotes HCC Ferroptosis and Synergizes with Anti‐PD‐1 Immunotherapy
por: Zheng, Yimin, et al.
Publicado: (2023)

Identification of potential miRNA–mRNA regulatory network contributing to pathogenesis of HBV-related HCC
por: Lou, Weiyang, et al.
Publicado: (2019)

Conversion of Minimally Invasive Liver Resection for HCC in Advanced Cirrhosis: Clinical Impact and Role of Difficulty Scoring Systems
por: Cipriani, Federica, et al.
Publicado: (2023)

Age-specific and sex-specific risks for HCC in African-born persons with chronic hepatitis B without cirrhosis
por: Kamal, Habiba, et al.
Publicado: (2023)

Influence of the CXCL1 rs4074 A Allele on Alcohol Induced Cirrhosis and HCC in Patients of European Descent
por: Nischalke, Hans Dieter, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_9c6t2nlp2jsnr6ut0ml75jfsu5